ALLIANCEBERNSTEIN L.P. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$12,486,731
+67.6%
44,570
+59.7%
0.00%
+33.3%
Q1 2024$7,450,416
-90.5%
27,900
-91.8%
0.00%
-90.0%
Q4 2023$78,612,281
+49.1%
339,754
-5.9%
0.03%
+36.4%
Q3 2023$52,717,081
-38.5%
360,977
-2.7%
0.02%
-37.1%
Q2 2023$85,727,796
+1395.1%
371,116
+1468.0%
0.04%
+1650.0%
Q1 2023$5,733,810
-20.9%
23,668
-5.2%
0.00%
-33.3%
Q4 2022$7,246,962
+567.9%
24,968
+49.5%
0.00%
+200.0%
Q3 2022$1,085,000
-9.2%
16,7000.0%0.00%0.0%
Q2 2022$1,195,000
-27.1%
16,7000.0%0.00%0.0%
Q1 2022$1,639,000
+16.5%
16,700
+0.6%
0.00%
Q4 2021$1,407,000
+6.2%
16,6000.0%0.00%
-100.0%
Q3 2021$1,325,000
-18.1%
16,6000.0%0.00%0.0%
Q2 2021$1,617,000
-16.7%
16,6000.0%0.00%0.0%
Q1 2021$1,942,000
-94.8%
16,600
-95.1%
0.00%
-94.4%
Q4 2020$37,677,000
-43.7%
338,914
-39.9%
0.02%
-50.0%
Q3 2020$66,959,000
+14.6%
563,962
+9.3%
0.04%
+5.9%
Q2 2020$58,436,000
+113.1%
515,994
+25.6%
0.03%
+70.0%
Q1 2020$27,423,000
-14.4%
410,764
+16.8%
0.02%
+11.1%
Q4 2019$32,038,000
+12.5%
351,641
+6.5%
0.02%0.0%
Q3 2019$28,470,000
-17.0%
330,197
+0.9%
0.02%
-14.3%
Q2 2019$34,310,000
-11.5%
327,352
+5.7%
0.02%
-16.0%
Q1 2019$38,781,000
+12.4%
309,605
+1.1%
0.02%
-3.8%
Q4 2018$34,507,000
-24.3%
306,134
+43.9%
0.03%
-13.3%
Q3 2018$45,558,000
-7.6%
212,760
+20.7%
0.03%
-11.8%
Q2 2018$49,289,000
+53.8%
176,228
-35.8%
0.03%
+47.8%
Q1 2018$32,042,000
+1817.5%
274,354
+1407.4%
0.02%
+2200.0%
Q4 2017$1,671,00018,2000.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Paulson & Co. 1,850,000$518,296,00038.31%
Tao Capital Management LP 130,529$36,569,00529.98%
University of Wisconsin Foundation 45,730$12,811,71714.42%
AlpInvest Partners B.V. 84,595$23,700,1358.50%
RTW INVESTMENTS, LP 1,915,862$536,747,8988.31%
Propel Bio Management, LLC 43,032$12,055,8457.82%
Avoro Capital Advisors LLC 2,055,555$575,884,2897.67%
Baker Brothers Advisors 1,974,590$553,201,1347.07%
Tri Locum Partners LP 65,352$18,309,0164.63%
TCG Crossover Management, LLC 149,283$41,823,1254.36%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders